You are here: Home » Companies » Industry
Business Standard

Regulator's moves worry pharma sector

Pharmaceutical industry is particularly worried that following the recent directives from the Supreme Court

BS Reporter  |  New Delhi 

The drug regulator’s recent suspension of Sun Pharmaceutical Industries’ clinical research activities at its Mumbai-based bio-analytical laboratory has raised concerns among other companies doing similar research and development work. The pharmaceutical industry is particularly worried that following the recent directives from the Supreme Court, the regulator may turn more stringent, impacting ongoing projects and future clearances. While the regulator has suspended Sun Pharma’s Mumbai laboratory citing absence of approval for the site, the firm maintains it has ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, November 09 2013. 00:36 IST
RECOMMENDED FOR YOU